These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Giacomelli R, Matucci-Cerinic M, Cipriani P, Ghersetich I, Lattanzio R, Pavan A, Pignone A, Cagnoni ML, Lotti T, Tonietti G. Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091 [Abstract] [Full Text] [Related]
3. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Manetti M, Guiducci S, Romano E, Bellando-Randone S, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M. Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486 [Abstract] [Full Text] [Related]
4. Localization of endothelin-1 and its binding sites in scleroderma skin. Vancheeswaran R, Azam A, Black C, Dashwood MR. J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957 [Abstract] [Full Text] [Related]
5. Increased expression of basic fibroblast growth factor in skin of patients with systemic sclerosis. Lawrence A, Khanna D, Misra R, Aggarwal A. Dermatol Online J; 2006 Jan 27; 12(1):2. PubMed ID: 16638370 [Abstract] [Full Text] [Related]
8. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement. Del Rosso A, Distler O, Milia AF, Emanueli C, Ibba-Manneschi L, Guiducci S, Conforti ML, Generini S, Pignone A, Gay S, Madeddu P, Matucci-Cerinic M. Ann Rheum Dis; 2005 Mar 27; 64(3):382-7. PubMed ID: 15708892 [Abstract] [Full Text] [Related]
9. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma). Sprott H, Müller-Ladner U, Distler O, Gay RE, Barnum SR, Landthaler M, Schölmerich J, Lang B, Gay S. J Rheumatol; 2000 Feb 27; 27(2):402-4. PubMed ID: 10685805 [Abstract] [Full Text] [Related]
10. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Kissin EY, Merkel PA, Lafyatis R. Arthritis Rheum; 2006 Nov 27; 54(11):3655-60. PubMed ID: 17075814 [Abstract] [Full Text] [Related]
11. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis. Yanaba K, Muroi E, Yoshizaki A, Hara T, Ogawa F, Shimizu K, Yozaki M, Hasegawa M, Fujimoto M, Takehara K, Sato S. J Rheumatol; 2009 Sep 27; 36(9):1917-23. PubMed ID: 19605674 [Abstract] [Full Text] [Related]
13. Expression of human leukocyte antigen-G in systemic lupus erythematosus. Rosado S, Perez-Chacon G, Mellor-Pita S, Sanchez-Vegazo I, Bellas-Menendez C, Citores MJ, Losada-Fernandez I, Martin-Donaire T, Rebolleda N, Perez-Aciego P. Hum Immunol; 2008 Jan 27; 69(1):9-15. PubMed ID: 18295670 [Abstract] [Full Text] [Related]
14. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Davies CA, Jeziorska M, Freemont AJ, Herrick AL. Rheumatology (Oxford); 2006 Nov 27; 45(11):1349-55. PubMed ID: 17050587 [Abstract] [Full Text] [Related]
15. Expression of HLA class II antigens on skin fibroblasts in scleroderma. Branchet MC, Boisnic S, Blétry O, Robert L, Charron D, Francès C. Br J Dermatol; 1992 May 27; 126(5):431-5. PubMed ID: 1610682 [Abstract] [Full Text] [Related]
20. Evidence of 5-lipoxygenase overexpression in the skin of patients with systemic sclerosis: a newly identified pathway to skin inflammation in systemic sclerosis. Kowal-Bielecka O, Distler O, Neidhart M, Künzler P, Rethage J, Nawrath M, Carossino A, Pap T, Müller-Ladner U, Michel BA, Sierakowski S, Matucci-Cerinic M, Gay RE, Gay S. Arthritis Rheum; 2001 Aug 27; 44(8):1865-75. PubMed ID: 11508440 [Abstract] [Full Text] [Related] Page: [Next] [New Search]